CorVista Health, formely known as Analytics 4 Life, is a digital health company dedicated to improving cardiovascular disease diagnosis.
CorVista® Health's goal is to transform healthcare with digital technology – beginning with coronary artery disease.
CorVista was founded in 2012 by Sunny Gupta. The company is based in Toronto, Ontario with an additional office in Cary, North Carolina.
CorVista® Health is pioneering digital health using disciplines of advanced mathematics and physics, artificial intelligence and cloud computing to develop diagnostic solutions to transform the way cardiovascular diseases are diagnosed.
CorVista Health has developed CorVista® System, a non-invasive point-of-care solution that is intended to synchronously collect and apply machine learning to a patient’s cardiac and hemodynamic signals to predict the likelihood of cardiovascular diseases without the use of radiation, contrast agents, injections, fasting or exercise.
Within minutes of the test, the CorVista® Analysis is available in a secure web portal to aid physicians in rapidly diagnosing and treating patients with suspected cardiovascular disease, answering important clinical questions to guide better treatment decisions.
CorVista is backed by Ambix Life Science Fund I, L.P, MedVenture Partners, TM Capital, JLabs, Ontario Centres of Excellence and others. The company raised $65M in Series C round on Mar 04, 2021. This brings CorVista's total funding to $94M to date.